SCHEMBL1922484

SCHEMBL1922484

CC(=O)Cc1ccc(Br)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
MAPK1 P28482 1/20 0.43
PYCR1 P32322 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP3A4 P08684 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
KDM5A P29375 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
RXRA P19793 2/20 0.37
RXRB P28702 2/20 0.37
CUL4A Q13619 1/20 0.37
ALDH1A1 P00352 4/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
POLB P06746 1/20 0.37
SETDB1 Q15047 1/20 0.37
MAOB P27338 1/20 0.37
RXRG P48443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30354629 0.85 RXRA (0.51) MAPTPYCR1MEN1KMT2ANPSR1
SCHEMBL5985 0.85 RXRA (0.51) MAPTPYCR1MEN1KMT2ANPSR1
SCHEMBL3474780 0.83 SIRT1 (0.42) MAPTPYCR1MEN1KMT2ANPSR1
SCHEMBL15658116 0.81 MAPT (0.46) MAPTMAPK1CYP3A4CUL4AGAA
SCHEMBL9539850 0.80 MEN1 (0.44) MAPTPYCR1MEN1KMT2ACYP3A4
SCHEMBL13751380 0.80 HPGD (0.45) MAPTPYCR1MEN1KMT2AALDH1A1
SCHEMBL4050941 0.80 NPC1 (0.45) PYCR1MEN1KMT2ACYP3A4NPSR1
SCHEMBL2254145 0.80 MTNR1A (0.48) MAPTPYCR1MEN1KMT2ANPSR1
SCHEMBL8444 0.79 DGAT1 (0.46) MAPTMAPK1PYCR1MEN1KMT2A
SCHEMBL16097462 0.79 KDM4E (0.43) MAPTMAPK1CYP3A4CUL4APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328902-A1 PYRAZOLO [5,1-B]OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS Novartis AG (CH) 2011-06-08 EP disclosed
WO-2010015628-A1 PYRAZOLO [5,1-B] OXAZOLE DERIVATIVES AS CRF1 ANTAGONISTS NOVARTIS AG (CH) 2010-02-11 WO disclosed